The spectrum of behaviors influenced by serotonin

Biological Psychiatry

Volumn 44, Issue 3, 1998, Pages 151-162

  Lucki, Irwin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Aggression; Anxiety; Behavior; Depression; Feeding; Neuroendocrinology; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ANTIDEPRESSANT AGENT; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

AGGRESSION; ANIMAL BEHAVIOR; ANXIETY; BEHAVIOR; DEPRESSION; EATING DISORDER; FEEDING BEHAVIOR; HUMAN; MOTOR ACTIVITY; NEUROENDOCRINOLOGY; NEUROTRANSMISSION; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SATIETY; SEROTONINERGIC SYSTEM; SOCIAL BEHAVIOR;

EID: 0032145210     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00139-5     Document Type: Article

References (114)

1. Adell A., Casanovas J.M., Artigas F. Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas. Neuropharmacology. 36:1997;735-741.
2. Artigas F. Selective serotonin noradrenaline reuptake inhibitors (SNRIs) - Pharmacology and therapeutic potential in the treatment of depressive disorders. CNS Drugs. 4:1995;79-89.
3. Asberg M. Monoamine neurotransmitters in human aggressiveness and violence A selective review . Criminal Behav Ment Hlth. 4:1994;303-327.
4. 2 receptor agonist-induced oxytocin, prolactin, and corticosterone responses. Endocrinology. 134:1994;1127-1131.
5. Banky A., Halasz B., Nagy G. Circadian corticosterone rhythm did not develop in rats seven weeks after destruction with 5,7-dihydroxytryptamine of the serotoninergic nerve terminals in the suprachiasmatic nucleus at the age of 16 days. Brain Res. 369:1986;119-124.
6. Barden N., Reul J.M.H.M., Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci. 18:1995;6-11.
7. Barrett J.E., Vanover K.E. 5-HT receptors as targets for the development of novel anxiolytic drugs Models, mechanisms and future directions . Psychopharmacology (Berl). 112:1993;1-12.
8. Baumgarten H.G., Grozdanovic Z. Psychopharmacology of central serotonergic systems. Pharmacopsychiatry. 28:(suppl 2):1995;73-79.
9. Bizot J.C., Thiébot M.H., Le Bihan C., Soubié P., Simon P. Effects of imipramine-like drugs and serotonin uptake blockers on delay of reward in rats. Possible implication in the behavioral mechanism of action of antidepressants. J Pharmacol Exp Ther. 246:1988;1144-1151.
10. Borsini F. Role of the serotonergic system in the forced swimming test. Neurosci Biobehav Rev. 19:1995;377-395.
11. Borsini F., Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology (Berl). 94:1988;147-160.
12. Bowen D.M., Francis P.T., Chessell I.P., Webster M.T. Neurotransmission - The link integrating Alzheimer's disease? Trends Neurosci. 17:1994;149-150.
13. Brodie B.B., Shore P.A. A concept for the role of serotonin and norepinephrine as chemical mediators in the brain. Ann NY Acad Sci. 66:1957;631-642.
14. Brown G.L., Goodwin F.K. Cerebrospinal fluid correlates of suicide attempts and aggression. Ann NY Acad Sci. 487:1986;175-188.
15. Brown G.L., Linnoila M.I. CSF serotonin metabolite (5-HIAA) studies in depression, impulsivity and violence. J Clin Psychiatry. 51:(suppl 4):1990;31-41.
16. Cairncross K.D., Cox B., Forster C., Wren A.F. A new model for the detection of antidepressant drugs Olfactory bulbectomy in the rat compared with existing models . J Pharmacol Meth. 1:1978;131-143.
17. 1A receptor gene expression by dexamethasone. Neuropsychopharmacology. 10:1994;215-222.
18. Chaouloff F. Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Rev. 18:1993;1-32.
19. Coccaro E.F., Berman M.E., Kavoussi R.J., Hauger R.L. Relationship of prolactin response to d-fenfluramine to behavioral and questionnaire assessments of aggression in personality-disordered men. Biol Psychiatry. 40:1996;157-164.
20. Cullinan W.E., Herman J.P., Battaglia D.F., Akil H., Watson S.J. Pattern and time course of immediate early gene expression in rat brain following acute stress. Neuroscience. 64:1995;477-505.
21. Dahlstrom A., Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brainstem neurons. Acta Physiol Scand. 62:(suppl 232):1964;1-55.
22. Delgado P.L., Price L.H., Miller H.L., Salomon R.M., Licinio J., Krystal J.H., et al. Rapid serotonin depletion as a provocative challenge test for patients with major depression Relevance to antidepressant action and the neurobiology of depression . Psychopharmacol Bull. 27:1991;321-330.
23. Delgado P.L., Miller H.L., Salomon R.M., Licinio J., Heninger G.R., Gelenberg A.J., et al. Monoamines and the mechanism of antidepressant action Effects of catecholamine depletion on mood of patients treated with antidepressants . Psychopharmacol Bull. 29:1993;389-396.
24. Depue R.A., Spoont M.R. Conceptualizing a serotonin trait A behavioral dimension of constraint . Ann NY Acad Sci. 487:1986;47-62.
25. Detke M.J., Lucki I. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test The effects of water depth . Behav Brain Res. 73:1995;43-46.
26. Detke M.J., Kirby L., Lucki I. Serotonergic mechanisms involved in the effects of fluoxetine in the rat forced swimming test (FST). Soc Neurosci Abstr. 21:1995;976.
27. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl). 121:1995;66-72.
28. Detke M.J., Johnson J., Lucki I. Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp Clin Psychopharmacol. 5:1997;107-112.
29. 1A receptor agonists Recent developments and controversial issues . Psychopharmacology (Berl). 121:1995;1-26.
30. Duncan G.E., Johnson K.B., Breese G.R. Topographic patterns of brain activity in response to swim stress Assessment by 2-deoxyglucose uptake and expression of fos-like immunoreactivity . J Neurosci. 13:1993;3932-3943.
31. Eison A.S., Eison M.S. Serotonergic mechanisms in anxiety. Prog Neuropsychopharmacol Biol Psychiatry. 18:1994;47-62.
32. Erspamer V., Asero B. Identification of enteramine, specific hormone of enterochromaffin system, as 5-hydroxytryptamine. Nature. 169:1952;800.
33. Feldman S., Weidenfeld J., Conforti N., Saphier D. Differential recover of adrenocortical responses to neural stimuli following administration of 5,7-dihydroxytryptamine into the hypothalamus. Exp Brain Res. 85:1991;144-148.
34. Fletcher P.J., Currie P.J., Chambers J.W., Coscina D.V. Radiofrequency lesions of the PVN fail to modify the effects of serotonergic drugs on food intake. Brain Res. 630:1993;1-9.
35. Fuller R.W. Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats. Behav Brain Res. 73:1996;215-219.
36. Glennon R.A., Lucki I. Behaviors associated with the activation of serotonin receptors. Sanders-Bush E. The Serotonin Receptors. 1988;253-293 Humana Press, New York.
37. Handley S.L., McBlane J.W. 5HT drugs in animal models of anxiety. Psychopharmacology (Berl). 112:1993;13-20.
38. Hansen H.H., Sanchez C., Meier E. Neonatal administration of the selective serotonin reuptake inhibitor Lu 10-134-C increases forced swimming-induced immobility in adult rats A putative animal model of depression? J Pharmacol Exp Ther. 283:1997;1333-1341.
39. Hemby S.E., Lucki I., Gatto G., Singh A., Thornley C., Matasi J., et al. Potential antidepressant effects of novel tropane compounds selective for serotonin or dopamine transporters. J Pharmacol Exp Ther. 282:1997;727-733.
40. Heninger G.R., Delgado P.L., Charney D.S. The revised monoamine theory of depression A modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans . Pharmacopsychiatry. 29:1996;2-11.
41. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev. 46:1994;157-204.
42. Jacobs B.L. An animal behavior model for studying central serotonergic synapses. Life Sci. 19:1976;777-785.
43. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol Rev. 72:1992;165-229.
44. Jacobs B.L., Fornal C.A. Serotonin and behavior A general hypothesis . Bloom F.E., Kupfer D.J. Psychopharmacology The Fourth Generation of Progress . 1995;461-469 Raven Press, New York.
45. Joly D., Sanger D.J. The effects of fluoxetine and zimeldine on the behavior of olfactory bulbectomized rats. Pharmacol Biochem Behav. 24:1986;199-204.
46. Katz M.M., Maas J.W., Frazer A., Koslow S.H., Bowden C.L., Berman N., et al. Drug-induced actions on brain neurotransmitter systems and changes in the behaviors and emotions of depressed patients. Neuropsychopharmacology. 11:1994;89-100.
47. Kirby L.G., Lucki I. Interaction between the forced swimming test and fluoxetine treatment on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat. J Pharmacol Exp Ther. 282:1997;967-976.
48. Kirby LG, Lucki I (in press): The effect of repeated exposure to forced swimming on extracellular levels of 5-hydroxytryptamine in the rat. Stress.
49. Kirby L.G., Allen A.R., Lucki I. Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res. 682:1995;189-196.
50. Kirby L.G., Chou-Green J.M., Davis K., Lucki I. The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res. 760:1997;218-230.
51. Leibowitz S.F. Hypothalamic serotonin in relation to appetite for macronutrients and eating disorders. Vanhoutte P.M., Saxena P.R., Paoletti R., Brunello N., Jackson A.S. Serotonin From Cell Biology to Pharmacology and Therapeutics . 1993;383-391 Kluwer Academic Publishers, Boston.
52. Leshner A.I., Remler H., Biegon A., Samuel D. Effects of desmethylimipramine (DMI) on learned helplessness. Psychopharmacology (Berl). 66:1979;207-213.
53. Liposits Z.S., Phelix C., Paull W.K. Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat A light and electron microscopic immunocytochemical study . Histochemistry. 86:1987;541-549.
54. Lorrain D.S., Matuszewich L., Friedman R.D., Hull E.M. Extracellular serotonin in the lateral hypothalamic area is increased during the postejaculatory interval and impairs copulation in male rats. J Neurosci. 17:1997;9361-9366.
55. Lucki I. Serotonin receptor specificity in anxiety disorders. J Clin Psychiatry. 57:(suppl 6):1996;5-10.
56. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol. 8:1997;523-532.
57. Lucki I., Singh A., Kreiss D.S. Antidepressant-like behavioral effects of serotonin receptor agonists. Neurosci Biobehav Rev. 18:1994;85-95.
58. Maes M., Meltzer H.Y. The serotonin hypothesis of major depression. Bloom F.E., Kupfer D.J. Psychopharmacology The Fourth Generation of Progress . 1995;933-944 Raven Press, New York.
59. 1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior. J Pharmacol Exp Ther. 250:1989;60-71.
60. Martin P., Soubrié P., Puech A.J. Reversal of helplessness behavior by serotonin uptake blockers in rats. Psychopharmacology (Berl). 101:1990;403-407.
61. McGuirk J., Muscat R., Willner P. Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence. Psychopharmacology (Berl). 106:1992;401-407.
62. McLoughlin D.M., Lucey J.V., Dinan T.G. Central serotonergic hyperresponsivity in late-onset Alzheimer's disease. Am J Psychiatry. 151:1994;1701-1703.
63. Mehlman P.T., Higley J.D., Faucher I., Lilly A.A., Taub D.M., Vickers J., et al. Low CSF 5-HIAA concentrations and severe aggression and impaired impulse control in nonhuman primates. Am J Psychiatry. 15:1994;1485-1491.
64. 1A receptors in rat forebrain. Neuroendocrinology. 56:1992;881-888.
65. Miczek K.A., Donat P. Brain 5-HT systems and inhibition of aggressive behavior. Bevan P., Cools A.R., Archer T. Behavioral Pharmacology of 5-HT. 1989;117-144 Lawrence Erlbaum, Hillsdale, NJ.
66. Miczek KA, Haney M, Tidey J, Vivian J, Weerts E (1994): Neurochemistry and pharmacotherapeutic management of aggression and violence. In: Reiss AJ, Miczek KA. Roth JA, editors. Understanding and Preventing Violence, vol 2: Biobehavioral Influences. Washington, DC: National Academy Press, pp 245-513.
67. Murphy D.L., Aulakh C., Mazzola-Pomietto P., Briggs N.C. Neuroendocrine responses to serotonergic agonists as indices of the functional status of central serotonin neurotransmission in humans A preliminary comparative analysis of neuroendocrine endpoints versus other endpoint measures . Behav Brain Res. 73:1996;209-214.
68. Muscat R., Papp M., Willner P. Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline. Psychopharmacology (Berl). 109:1992;433-438.
69. Olivier B., Mos J., van Oorschot R., Hen R. Serotonin receptors and animal models of aggressive behavior. Pharmacopsychiatry. 28:(suppl 2):1995;80-90.
70. Orosco M., Nicolaidis S. Insulin and glucose-induced changes in feeding and medial hypothalamic monoamines revealed by microdialysis in rats. Brain Res Bull. 33:1994;289-297.
71. Parsons L.H., Koob G.F., Weiss F. Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J Pharmacol Exp Ther. 274:1995;1182-1191.
72. Peyron C., Petit J.-M., Rampon C., Jouvet M., Luppi P.-H. Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods. Neuroscience. 82:1998;443-468.
73. Porsolt R.D., Le Pichon M., Jalfre M. Depression A new animal model sensitive to antidepressant treatments . Nature. 266:1977;730-732.
74. Porsolt R.D., Anton G., Deniel M., Jalfre M. Behavioral despair in rats A new model sensitive to antidepressant treatments . Eur J Pharmacol. 47:1978;379-391.
75. Price M.L., Curtis A.L., Kirby L.G., Valentino R.J., Lucki I. Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology. 18:1998;492-502.
76. Raleigh M.J., Brammer G.L., Yuwiler A., Flannery J.W., McGuire M.T., Geller E. Serotonergic influences on the social behavior of vervet monkeys (Ceropithecus aethiops sabaeus). Exp Neurol. 68:1980;322-334.
77. Raleigh M.J., Brammer G.L., McGuire M.T. Male dominance, serotonergic systems, and the behavioral and physiological effects of drugs in vervet monkeys (Ceropithecus aethiops sabaeus). Miczek K.A. Ethopharmacology Primate Models of Neuropsychiatric Disorders . 1983;184-198 Liss, New York.
78. Raleigh M.J., McGuire M.T., Brammer G.L., Pollack D.B. Serotonergic mechanisms promote dominance acquisition in adult male vervet monkeys. Brain Res. 559:1991;181-190.
79. Rapport M.M., Green A.A., Page I.H. Crystalline serotonin. Science. 108:1948;329-330.
80. Reneric J.P., Lucki I. Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology (Berl). 136:1998;190-197.
81. Rueter L.E., Fornal C.A., Jacobs B.L. A critical review of 5-HT brain microdialysis and behavior. Rev Neurosci. 8:1997;117-137.
82. Sapolsky R.M., Krey L.C., McEwen B.S. Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proc Natl Acad Sci USA. 81:1984;6174-6177.
83. 1B receptor. Science. 265:1994;1875-1878.
84. Schwartz D.H., Hernandez L., Hoebel B.G. Serotonin release in lateral and medial hypothalamus during feeding and its anticipation. Brain Res Bull. 25:1990;797-802.
85. Seckl J.R., Fink G. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology. 55:1992;621-626.
86. Seckl J.R., Dickson K.L., Fink G. Central 5,7-dihydroxytryptamine lesions decrease hippocampal glucocorticoid and mineralocorticoid receptor messenger ribonucleic acid expression. J Neuroendocrinol. 2:1990;911-916.
87. Seiden L.S., O'Donnell J.M. Effects of antidepressant drugs on DRL behavior. Seiden L.S., Balster R.L. Behavioral Pharmacology The Current Status . 1985;323-338 Liss, New York.
88. Seligman M.E.P., Rossellini R., Kozak M. Learned helplessness in the rat Reversibility, time course and immunization . J Comp Physiol Psychol. 88:1975;542-547.
89. Sherman A.D., Sacquitne J.L., Petty F. Specificity of the learned helplessness model of depression. Pharmacol Biochem Behav. 16:1982;449-454.
90. Shopsin B., Gershon S., Goldstein M., Friedman E., Wilk S. Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients. Psychopharmacol Commun. 1:1975;239-249.
91. Shopsin B., Friedman E., Gershon S. Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients. Arch Gen Psychiatry. 33:1976;811-819.
92. 2a receptor induces an antidepressant-like effect in mice. Mol Pharmacol. 52:1997;1056-1063.
93. Simansky K.J. Serotonergic control of the organization of feeding and satiety. Behav Brain Res. 73:1996;37-42.
94. Simansky K.J. 5-HT receptor subtypes influencing feeding and drinking Focus on the periphery . Cooper S.J., Clifton P.G. Drug Receptor Subtypes and Ingestive Behaviour. 1996;59-97 Academic Press, London.
95. Simansky K.J., Vaidya A.H. Behavioral mechanisms for the anorectic action of the serotonin (5-HT) uptake inhibitor sertraline in rats Comparison with directly acting 5-HT agonists . Brain Res Bull. 25:1990;953-960.
96. Soubrie P. Reconciling the role of central serotonin neurons in human and animal behavior. Behav Brain Sci. 9:1986;319-364.
97. Spoont M.R. Modulatory role of serotonin in neural information processing Implications for human psychopathology . Psychol Bull. 112:1992;330-350.
98. 1A receptors and 5-HT uptake sites in the hippocampus and dorsal raphe nucleus of the rat brain An autoradiographic analysis . Psychopharmacology (Berl). 113:1994;481-486.
99. Thomas E. Forebrain mechanisms in the relief of fear The role of the lateral septum . Psychobiology. 16:1988;36-44.
100. Tuinier S., Verhoeven W.M.A., van Praag H.M. Cerebrospinal fluid 5-hydroxyindolacetic acid and aggression A critical reappraisal of the clinical data . Int Clin Psychopharmacol. 10:1995;147-156.
101. Valentino R.J., Foote S.L., Page M.E. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann NY Acad Sci. 697:1993;173-188.
102. Van de Kar L.D., Richardson-Morton K.D., Rittenhouse P.A. Stress Neuroendocrine and pharmacological mechanisms . Jasmin G., Cantin M. Stress Revisited. 1. Neuroendocrinology of Stress (Methods and Achievements in Experimental Pathology, vol 14). 1991;133-173 Karger, Basel.
103. Van de Kar L.D., Rittenhouse P.A., Li Q., Levy A.D. Serotonergic regulation of renin and prolactin secretion. Behav Brain Res. 73:1996;203-208.
104. 1A receptor ligands on rat dorso-lateral septal neurones in vitro. Br J Pharmacol. 106:1992;893-899.
105. van Erp A.M.M., Miczek K.A. Aggressive behavior decreases cortical 5HT in rats Reversal by ethanol drinking . Soc Neurosci Abstr. 23:1997;801.
106. Weidenfeld J., Corcos A.P., Wohlman A., Feldman S. Characterization of the 2-deoxyglucose effect on the adrenocortical axis. Endocrinology. 134:1994;1924-1931.
107. Weiss J.M., Kilts C.D. Animal models of depression and schizophrenia. Nemeroff C.B., Schatzberg A.F. American Psychiatric Press Textbook of Psychopharmacology. 1995;81-123 American Psychiatric Press, Washington, DC.
108. Weiss F., Parsons L.H., Schulteis G., Hyytia P., Lorang M.T., Bloom F.E., et al. Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J Neurosci. 16:1996;3474-3485.
109. Wilkinson L.S., Humby T., Killcross S., Robbins T.W., Everitt B.J. Dissociations in hippocampal 5-hydroxytryptamine release in the rat following Pavlovian aversive conditioning to discrete and contextual stimuli. Eur J Neurosci. 8:1996;1479-1487.
110. Willner P. Animal models of depression An overview . Pharmacol Ther. 45:1990;425-455.
111. Willner P., Muscat R., Papp M. Chronic mild stress-induced anhedonia A realistic animal model of depression . Neurosci Biobehav Rev. 16:1992;525-534.
112. Wong D.T., Bymaster F.P., Engleman E.A. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug Twenty years since its first publication . Life Sci. 57:1995;411-441.
113. Wright I.K., Upton N., Marsden C.A. Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze. Psychopharmacology (Berl). 109:1992;338-346.
114. Yatham L.N., Steiner M. Neuroendocrine probes of serotonergic function A critical review . Life Sci. 53:1993;447-463.